Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating CKD-333 tablet for safety and efficacy in hypertensive patients with dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension with Dyslipidemia

Drugs mentioned

• CKD-333

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertensive Patients With Dyslipidemia | Phase 3 | Status: COMPLETED